We are live on
!
Find out more
IHAM
Integral Health Asset Management Portfolio holdings
AUM
$2.09B
1-Year Est. Return
112.84%
This Fund
S&P 500
This Quarter
Est. Return
+8.83%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$1.17B
AUM Growth
+$284M
(+32%)
Cap. Flow
+$340M
Cap. Flow
% of AUM
29%
Top 10 Holdings %
Top 10 Hldgs %
38.67%
Holding
102
New
36
Increased
28
Reduced
14
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$31.2M |
| 2 |
Cardinal Health
CAH
|
+$29.2M |
| 3 |
Vera Therapeutics
VERA
|
+$28.8M |
| 4 |
CVS Health
CVS
|
+$28.1M |
| 5 |
Eli Lilly
LLY
|
+$23.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LBPH
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
|
+$35M |
| 2 |
Novartis
NVS
|
+$23M |
| 3 |
Tenet Healthcare
THC
|
+$19.3M |
| 4 |
ACLX
Arcellx
ACLX
|
+$15.1M |
| 5 |
Medtronic
MDT
|
+$13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 96.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Viridian Therapeutics
VRDN
$2.6B
| – | – |
-250,000
| Closed | -$5.69M |
|
|
LBPH
102
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| – | – |
-1,050,000
| Closed | -$35M |
|
Similar funds
CL
ACM
ACG
NSUP
TP
ACP
TA
AG
Integral Health Asset Management's Q4 2024 Portfolio in Review
As of Q4 2024, Integral Health Asset Management held 102 positions worth $1.17B, up 32% from $889M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Integral Health Asset Management deployed $340M of net new capital in Q4 2024, opening 36 new positions and adding to 28 existing holdings. Its largest new stake was Centene: 500,000 shares worth $30.3M.
By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 96% a quarter earlier.
On the sell side, the largest reduction was Tenet Healthcare, an estimated $19.3M trimmed.
- Integral Health Asset Management's largest Q4 2024 buy was Centene: 500,000 shares worth $30.3M.
- Integral Health Asset Management added most to Vera Therapeutics in Q4 2024, an estimated $28.8M increase.
- Integral Health Asset Management's biggest Q4 2024 reduction was Tenet Healthcare, cutting an estimated $19.3M.
- Integral Health Asset Management fully exited Longboard Pharmaceuticals, Inc. Common Stock in Q4 2024, selling an estimated $35M.
- Integral Health Asset Management's ten largest holdings make up 39% of its $1.17B portfolio in Q4 2024.
- Integral Health Asset Management opened 36 new positions and closed 19 in Q4 2024.
- Integral Health Asset Management's portfolio value rose 32% quarter-over-quarter to $1.17B.
Based on Integral Health Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.